Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Syntaxin 1 is an essential component of the neurotransmitter release machinery, and regulation of syntaxin 1 expression levels is thought to contribute to the mechanism underlying learning and memory. However, the molecular events that control the degradation of syntaxin 1 remain undefined. Here we report the identification and characterization of a novel RING finger protein,
Staring
, that interacts with syntaxin 1.
Staring
is expressed throughout the brain, where it exists in both cytosolic and membrane-associated pools.
Staring
binds and recruits the brain-enriched E2 ubiquitin-conjugating enzyme UbcH8 to syntaxin 1 and facilitates the ubiquitination and
proteasome
-dependent degradation of syntaxin 1. These findings suggest that
Staring
is a novel E3 ubiquitin-protein ligase that targets syntaxin 1 for degradation by the ubiquitin-
proteasome
pathway.
...
PMID:Staring, a novel E3 ubiquitin-protein ligase that targets syntaxin 1 for degradation. 1212 82